Tricuspid Regurgitation Impact on Outcomes Score for Risk Stratification in Patients With Pulmonary Hypertension
J Am Soc Echocardiogr
.
2023 Nov;36(11):1213-1215.
doi: 10.1016/j.echo.2023.07.005.
Epub 2023 Jul 23.
Authors
Mohamad S Alabdaljabar
1
,
Jwan A Naser
2
,
Conor J Kane
3
,
Kyla M Lara-Breitinger
4
,
Vidhu Anand
4
,
Cristina Pislaru
4
,
Mackram F Eleid
4
,
Mohamad A Alkhouli
4
,
Garvan C Kane
4
,
Patricia A Pellikka
4
,
Grace Lin
4
,
Vuyisile T Nkomo
4
,
Sorin V Pislaru
5
Affiliations
1
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
2
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
3
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota; School of Medicine, University College Dublin, Dublin, Ireland.
4
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
5
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: Pislaru.Sorin@mayo.edu.
PMID:
37490988
DOI:
10.1016/j.echo.2023.07.005
No abstract available
MeSH terms
Echocardiography, Doppler
Humans
Hypertension, Pulmonary* / diagnosis
Risk Assessment
Tricuspid Valve
Tricuspid Valve Insufficiency* / diagnostic imaging